Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	(Accumulated Deficit) Retained Earnings	Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2021		131,161,404
Beginning balance at Dec. 31, 2021	$ 1,431,849	$ 13	$ 1,571,535	$ (1,099)	$ (138,600)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with a grant agreement (in shares)		881,365
Issuance of common stock in connection with a grant agreement	28,462		28,462
Vesting of restricted common stock (in shares)		349,496
Exercise of stock options (in shares)		696,963
Exercise of stock options	4,534		4,534
Issuance of common stock under employee stock purchase plan (in shares)		147,459
Issuance of common stock under employee stock purchase plan	3,222		3,222
Stock-based compensation	102,082		102,082
Other comprehensive (loss) income	(8,023)			(8,023)
Net income (loss)	515,837				515,837
Ending balance (in shares) at Dec. 31, 2022		133,236,687
Ending balance at Dec. 31, 2022	2,077,963	$ 13	1,709,835	(9,122)	377,237	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		734,662
Exercise of stock options (in shares)		487,014
Exercise of stock options	3,484		3,484
Issuance of common stock under employee stock purchase plan (in shares)		322,923
Issuance of common stock under employee stock purchase plan	4,283		4,283
Stock-based compensation	111,316		111,316
Other comprehensive (loss) income	8,307			8,307
Contributions from noncontrolling interest owners	100					100
Increase in ownership interest in a subsidiary	(100)		(56)			(44)
Net income (loss)	$ (615,117)				(615,061)	(56)
Ending balance (in shares) at Dec. 31, 2023	134,781,286	134,781,286
Ending balance at Dec. 31, 2023	$ 1,590,236	$ 13	1,828,862	(815)	(237,824)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		1,368,362
Vesting of restricted common stock	1	$ 1
Exercise of stock options (in shares)		322,366
Exercise of stock options	790		790
Issuance of common stock under employee stock purchase plan (in shares)		487,432
Issuance of common stock under employee stock purchase plan	3,763		3,763
Stock-based compensation	78,457		78,457
Other comprehensive (loss) income	(902)			(902)
Net income (loss)	$ (521,960)				(521,960)	0
Ending balance (in shares) at Dec. 31, 2024	136,959,446	136,959,446
Ending balance at Dec. 31, 2024	$ 1,150,385	$ 14	$ 1,911,872	$ (1,717)	$ (759,784)	$ 0